FLT3 is expressed at very high levels on the cells of more than 80% of AML patients (irrespective of French-American-British subtype), of a fraction of acute lymphoblastic leukemia cells ...

Acute myeloid leukemia (AML) is a cancer of immature blood cells. When the early myeloid cell matures normally, it will become either a mature white blood cell, red blood cell, or platelet.

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...